Neutralizing monoclonal antibody against botulinum neurotoxin serotype F
US5807741A · kind A · utility
29Cited by
0References
7Claims
0Family size
Inventors
Key dates
| Filing date | Jul 20, 1995 |
| Grant date | Sep 15, 1998 |
| Priority date | — |
| Expiry date | Jul 20, 2015 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibodies which neutralize botulinum neurotoxin serotype F are produced using biologically active botulinum neurotoxin instead of toxoid for immunization and exploiting the importance of cross reaction between various serotypes to obtain immune responses, or monoclonal antibodies, to additional serotypes of interest. Methods of preparation and uses of the neutralizing botulinum neurotoxin antibodies are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.